Lane 1: Hela cell lysate
Lane 2: Jurkat cell lysate
Recombinant Rabbit monoclonal primary
Recombinant Lamin B1 Monoclonal Antibody (ET1606-27)
Hela cell lysate, Jurkat cell lysate, human liver tissue, human colon carcinoma tissue, human breast carcinoma tissue, mouse colon tissue, mouse brain tissue.
Store at +4C after thawing. Aliquot store at -20C or -80C. Avoid repeated freeze / thaw cycles.
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Protein A affinity purified.
ADLD antibody; lamin B1 antibody; Lamin-B1 antibody; LMN antibody; LMN2 antibody; LMNB antibody; Lmnb1 antibody; LMNB1_HUMAN antibody; MGC111419 antibody; OTTHUMP00000159218 antibody
Belongs to the intermediate filament family.
B-type lamins undergo a series of modifications, such as farnesylation and phosphorylation. Increased phosphorylation of the lamins occurs before envelope disintegration and probably plays a role in regulating lamin associations.
Nucleus inner membrane.
A unique family of cysteine proteases has been described that differs in sequence, structure and substrate specificity from any previously described protease family. This family, termed Ced-3/ICE, functions as key components of the apoptotic machinery and act to destroy specific target proteins which are critical to cellular longevity. Nuclear lamins are critical to maintaining the integrity of the nuclear envelope and cellular morphology as components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin. B-type lamins undergo a series of modifications, such as farnesylation and phosphorylation. Increased phosphorylation of the lamins occurs before envelope disintegration and probably plays a role in regulating lamin associations. Nuclear Lamin B is fragmented as a consequence of apoptosis by an unidentified member of the ICE family.
Lin, Xiaoping et al.
Next-generation sequencing identified novel Desmoplakin frame-shift variant in patients with Arrhythmogenic cardiomyopathy. | Bmc Cardiovascular Disorders